Startseite>>Signaling Pathways>> PROTAC>>Amino-PEG11-amine

Amino-PEG11-amine

Katalog-Nr.GC63930

Amino-PEG11-Amin, ein PEG-basierter (12 Einheiten) PROTAC-Linker, der verwendet wird, um zwei Monodiethylstilbestrol (DES)-basierte Liganden zu kombinieren, bietet eine alternative Strategie zur Herstellung selektiverer und aktiverer ER-Antagonisten fÜr die endokrine Therapie von Brustkrebs.

Products are for research use only. Not for human use. We do not sell to patients.

Amino-PEG11-amine Chemische Struktur

Cas No.: 479200-82-3

Größe Preis Lagerbestand Menge
50 mg
162,00 $
Auf Lager
100 mg
261,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Amino-PEG11-amine, a PEG-based (12 units) PROTAC linker used to combine two mono diethylstilbestrol (DES)-based ligands, provides an alternative strategy for preparing more selective and active ER antagonists for endocrine therapy of breast cancer[1].

PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.

[1]. Shan M, et al. Nonsteroidal bivalent estrogen ligands: an application of the bivalent concept to the estrogen receptor. ACS Chem Biol. 2013 Apr 19;8(4):707-15.

Bewertungen

Review for Amino-PEG11-amine

Average Rating: 5 ★★★★★ (Based on Reviews and 27 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Amino-PEG11-amine

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.